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ABSTRACT 
 
As the leading source of cancer death among women worldwide, breast cancer has experienced a 
steady increase in prevalence in recently years, a trend that is most evident in industrialized 
nations. One possible explanation for this epidemic phenomenon is the exposure to light at night 
through shiftwork, which has been linked to both aberrant DNA methylation and increased risk 
of breast cancer development. Based on a whole-genome methylation analysis on a selected 
sample of the Danish Diet, Cancer and Health prospective cohort, we observed statistically 
significant hypomethylation in the PIWIL1 gene, a member of the PIWI protein family, among 
night shiftworkers. Upon analysis of expression microarray data from the Oncomine database, 
we observed a trend of PIWI gene overexpression in breast cancer patients relative to healthy 
controls. This finding was confirmed when we measured the endogenous expression of PIWI 
genes in breast cell lines, which revealed overexpression of PIWIL1 and PIWIL4 in breast 
cancer cells relative to normal breast cells. To further elucidate the functional link between PIWI 
gene expression and breast cancer, we knocked down PIWIL1 and L4 in breast cancer cells and 
observed a substantial decrease in the rate of cellular proliferation, which suggests that these 
genes may play a role in the breast carcinogenic process. Future in-depth investigation into the 
function of PIWI genes is warranted to gain a more comprehensive understand of their role in 
breast carcinogenesis.  
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LIST OF FIGURES 
 
Figure 1 Methylation indices for day workers and shiftworkers at PIWI-associated 
CpG sites. We observed a 13.14% decrease in methylation at a CpG site within 
PIWIL1’s proximal promoter region (Q=2.32*10-6), a 2.61% decrease at a CpG site 
within PIWIL1’s 5’UTR region (Q>0.05), a 4.94% decrease at a CpG site within 
PIWIL2’s 5’UTR region (Q>0.05), and a 0.04% decrease at a CpG site within PIWIL2’s 
proximate promoter region (Q>0.05). 
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Figure 2 PIWI gene expression in breast tumor tissues relative to normal tissues. We 
queried the Oncomine database for breast cancer studies with PIWI gene expression data. 
22 out of the 36 analyses found showed higher expression in one or more PIWI genes. 
Analyses exhibiting expression differences at P-values < 0.05 are marked with ‘*’. The 
size of each circle is scaled by the sample size of the corresponding analysis. Four 
subtypes of breast cancer are included in the analyses: invasive ductal breast carcinoma 
(IDBC), invasive breast carcinoma (IBC), ductal breast carcinoma (DBC), invasive 
lobular breast carcinoma (ILBC) and fibroadenoma (F). Figures 2A, 2B, 2C and 2D refer 
to the expression analyses for PIWIL1, PIWIL2, PIWIL3 and PIWIL4, respectively, in 
breast tumors compared to normal breast tissue. 
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Figure 3 PIWI Gene expression differences in MCF7 breast cancer cells compared 
to MCF10a normal cells. PIWI mRNAs expression levels in MCF7 cells and MCF10a 
cells were measured by quantitative real-time PCR performed in technical triplicate. 
RNA quantity was normalized using the HPRT housekeeping gene and quantified using 
the 2
-ΔΔCt
 method. Of the four PIWI Genes, PIWIL1, PIWIL3 and PIWIL4 were 5.57 
times, 4.194 times and 15.6 times overexpressed in MCF7 cells relative to that in 
MCF10a cells, while PIWIL2 was 4.193 times underexpressed in breast cancer cells 
compared to control. All of the expression differences achieved statistical significance 
(P<0.01). 
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Figure 4 PIWIL1/PIWIL4 expression differences in various cancer cell lines 
compared to normal cell lines. The mRNA expression of PIWIL1 and PIWIL4 were 
measured by quantitative real-time PCR performed in technical triplicate in three cancer 
types: breast cancer (MCF7 vs. MCF10a), cervical cancer (Hela vs. END1) and non-
Hodgkin’s lymphoma (Farrage vs. RPM1788). In cervical cancer cell lines, both PIWIL1 
and PIWIL4 were overexpressed compared to normal cells (8.95- and 3.97-fold, 
respectively). In non-Hodgkin’s lymphoma, PIWIL1 was 3.59 times overexpressed 
compared to the normal cells while PIWIL4 was 28.14 times underexpressed. All of the 
expression differences achieved statistical significance (P<0.01). 
 
 
* 
* 
* 
* 
* 
* 
* 
* 
* 
6 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Cell proliferation rates of MCF7 and MCF10a between PIWIL1 
knockdown group, PIWIL4 knockdown group and negative control. MCF7 and 
MCF10a cell proliferation rates were assessed at baseline, 24 hours, 48 hours, 72 hours, 
and 96 hours (and also at 120 hours and 144 hours for MCF7) following transfection with 
a PIWIL1/PIWIL4 targeting siRNA and a scrambled sequence negative control oligo. (A) 
Transfection with PIWIL1 targeting siRNA in MCF7 cells strongly slowed down cell 
proliferation compared to negative controls (P < 0.0001); (B) PIWIL1 knockdown only 
resulted in a moderate reduction in cell proliferation rate in MCF10a cells. (C) 
Transfection with PIWIL4 targeting siRNA in MCF7 cells greatly slowed down cell 
proliferation and even stopped growth altogether compared to negative controls (P < 
0.0001); (D) PIWIL4 knockdown resulted in a moderate reduction in cell proliferation 
rate in MCF10a cells. Error bars represent standard deviations. 
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Figure 6 Cell proliferation rates between PIWIL4 knockdown group and negative 
control in cervical cancer and non-Hodgkin’s lymphoma cell lines. Cell proliferation 
rates in cervical cancer and non-Hodgkin’s lymphoma cell lines were assessed at baseline, 
24 hours, 48 hours, 72 hours, and 96 hours following transfection with a PIWIL4 
targeting siRNA and a scrambled sequence negative control oligo. (A) Transfection with 
PIWIL4 targeting siRNA in HeLa cells significantly slowed down cell proliferation 
compared to negative controls (P < 0.0001); (B) PIWIL4 knockdown resulted in a 
moderate reduction in cell proliferation rate in END1 cells where the difference did not 
reach statistical significance (C) Transfection with PIWIL4 targeting siRNA in Farrage 
cells resulted in no difference in cell proliferation rate compared to negative controls (P > 
0.05); (D) Knocking down PIWIL4 resulted in no significant effect in cell proliferation 
rate in RPM1788 cells, as cells in the treatment group grew as quickly as those in the 
control group. Error bars represent standard deviations. 
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Figure 7 Western blotting and dot blotting for the confirmation of PIWIL4 
knockdown in MCF7/MCF10a Cells. Whole proteins were extracted from the 
following four groups: 7-NC: the negative control MCF7 cells; 7-L4: MCF7 cells 
transfected with PIWIL4 targeting siRNA; 10a-NC: the negative control MCF10a cells; 
10a-L4: MCF10a cells transfected with PIWIL4 targeting siRNA. The darkest band in 
the protein ladder corresponds to a protein size of 100KDa. (A) Western blotting: similar 
expression levels of β-actin were found in each of the four groups while no expression of 
PIWIL4 (protein size ~95KDa) was found in MCF7 cells and MCF10a cells transfected 
with PIWIL4 targeting siRNA. (B) Dot blotting results: the quantity of PIWIL4 proteins 
was larger in MCF7 negative control cells than that in MCF10a negative control cells. 
Both negative control groups had a much larger protein quantity of PIWIL4 compared to 
their respective siRNA transfected groups.  
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Figure 8 Known and predicted protein-protein interactions of PIWIL1 and PIWIL4 
Potential interactions between selected PIWI proteins and functionally related proteins 
were constructed using the STRING platform (version 9.0.5). Different line colors 
represent the different types of evidence underlying the interactions. (A) Existing 
evidence suggested that PIWIL1 interacted with several key components in RNA-
mediated gene silencing and transcriptional regulation, including DICER1, MOV10L1 
and Tudor domain related proteins. (B) Proteins predicted to interact with PIWIL4 
included RNA-mediated gene silencing factors like EIF2C2 and DICER1, Tudor domain 
related proteins like TDRD9, and regulatory factors of DNA methylation like DNMT3L. 
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INTRODUCTION 
Globally, breast cancer is the most common invasive cancer in women, comprising 
22.9% of invasive cancers in women and 16% of all female cancers. It is estimated that in 
2013 alone, 232,340 women were diagnosed with and 39,620 women died of breast 
cancer in the United States
1
. Meanwhile, the prevalence of breast cancer is steadily rising, 
with the highest risks observed in industrialized nations
2
. However, less than half the risk 
in industrialized areas is attributable to changes in known risk factors for breast cancer
3
.  
Among these risk factors, shiftwork has been investigated by multiple epidemiologic 
studies and identified by IARC as ‘probably carcinogenic to humans’. Although several 
findings have reported that people who work the night shift are at increased risk of 
developing breast cancer
4,5,6
, the detailed mechanism by which shiftwork can trigger 
tumorigenesis remains poorly understood. Our previous study, drawing from subjects of 
the Danish "Diet, Cancer and Health" prospective cohort, demonstrated significant 
epigenetic associations between the CLOCK and CRY2 circadian genes and night 
shiftwork using a whole-genome methylation screening approach. Based on the same 
approach, we recently discovered a significant change in PIWI gene methylation among 
night shiftworkers within the same population, which may provide additional insight into 
the molecular relationship between breast carcinogenesis and night shiftwork. 
PIWI proteins, which comprise a subclade of the Argonaute protein family, are known to 
play important roles in spermiogenesis
7
, stem cell self-renewal
8
, RNA silencing
9
, and 
translational regulation in a multitude of organisms
10,11
. Recently, an increasing body of 
evidence has accumulated and suggested that PIWI proteins are aberrantly expressed in a 
11 
 
 
variety of cancers
12
. However, thus far, only one study has ventured to study the 
relationship between PIWI genes and breast cancer. Moreover, despite the discovery of 
their expression in human somatic cancers, research on PIWI proteins in cancer remains 
at an early stage
13
, as very few studies have carefully examined the molecular 
mechanisms by which PIWI proteins contribute to tumorigenesis. 
In the present study, methylation changes in PIWI genes were examined using whole-
genome methylation analysis using subjects from the Danish shiftworker population, who 
have previously been reported to be at high risk for breast cancer
4
. In addition, we 
conducted expression analyses and in vitro functional tests to explore PIWI’s potential 
role in breast tumorigenesis. Finally, we explored potential molecular mechanisms 
underlying the observed PIWI gene expression changes and the functional impact 
imparted by PIWI gene downregulation in breast cancer cells. 
 
METHODS 
Study Subjects and Shiftwork Exposure Assessment 
As previously reported
14
, study subjects were selected among the female participants who 
were recruited to the Danish “Diet, Cancer and Health” prospective cohort15, established 
between December 1993 and May 1997. All female participants were born in Denmark, 
free of any cancer and aged between 50 and 64 years at time of invitation (now between 
65- and 79- years-old). Information on food consumption, folate intake, other lifestyle 
factors (e.g., tobacco smoking, alcohol habits, sun exposure, physical activity, and 
12 
 
 
medical anamnesis), reproductive factors, education and occupation were collected in the 
baseline questionnaire. All collected biological samples were frozen and kept at -150ᵒC. 
Blood DNA samples were available for methylation analysis.   
Night work was defined as having worked fulltime starting from 7 pm or later and ending 
before 9 am in the next day. Telephone interviews were conducted to obtain information 
on night shiftwork status. In the current study, ten female long-term night shiftworkers 
(age: 54.8±3.6, years of shiftwork: 21.2±8.8) were selected as the shiftworker group. Ten 
female day workers (age: 54.0±3.3, years of shiftwork: 0), matched to subjects of the 
shiftworker group by age (± 2 years) and total folate intake (± 55 μg/day), were selected 
for comparison with the shiftwork group. Additional details on the study poopulation 
have been described previously
16
. 
Genome-Wide CpG Island Methylation Assay  
Genomic DNA of 10 pairs of long-term night shiftworkers and day workers was isolated 
and purified from blood samples using the QIAamp DNA Blood Mini Kit (Qiagen) 
according to the manufacturer’s protocol. These genomic DNA were then bisulfite treated 
using the EZ DNA Methylation Kit (Zymo research). 50 ng of genomic DNA from each 
participant in both shiftworker were submitted to Yale University's W.M. Keck 
Foundation Biotechnology Research Laboratory for genome-wide DNA methylation 
measurements using Illumina's (San Diego, CA) Infinium HumanMethylation27 array 
platform. Quantitative measurements of DNA methylation were determined for 27,578 
CpG dinucleotides spanning 14,495 genes. Tested CpG sites include those located within 
the proximal promoter region of each gene, ranging from 0 to 1499 bp upstream of the 
13 
 
 
transcription start site (average ± SEM distance = 389 ± 34 bp). A methylation index (β) 
was used to estimate the methylation level of each CpG locus using the ratio of intensities 
between methylated and unmethylated cytosines, which is a continuous variable between 
0 and 1. 0 corresponds to a completely unmethylated site, while 1 corresponds to a 
completely methylated site. The Illumina Custom Model, as implemented in the Illumina 
GenomeStudio software, was used to assess the statistical significance of methylation 
differences between night shiftworkers and day workers. To correct for the increased 
likelihood of false positive differences resulting from multiple testing, the Benjamini-
Hochberg method was used to control for the False Discovery Rate (FDR), defined as the 
expected ratio of erroneous rejections of the null hypothesis to the total number of 
rejected hypotheses.  Methylation differences at CpG sites were considered statistically 
significant at a FDR-corrected P-value (Q-value) <0.05. 
Data mining of PIWI expression in breast cancer and other tumor types 
A comprehensive search using the Oncomine online database (https://www.oncomine.org; 
accessed on November 29th, 2013) was performed to investigate whether PIWI gene 
expression are altered in breast cancer as well as other cancer types.  Comparisons were 
made based on for expression array results involving tissues drawn from cancer patients 
and healthy controls. The filters used were: Gene: "PIWIL1", "PIWIL2", "PIWIL3", or 
"PIWIL4"; Analysis Type: "Cancer vs. Normal Analysis"; Caner Type: "Breast Cancer". 
The search returned a total of 36 analyses conducted in 12 unique studies for breast 
cancer using different array platforms (10 for PIWIL1, 9 for PIWIL2, 4 for PIWIL3 and 
13 for PIWIL4 respectively). Further details regarding tissue collection and the 
14 
 
 
experimental protocol of each array are available in the Oncomine database, or from the 
original publications. 
Cell culture and treatments 
All experimental procedures were approved by the Institutional Review Board at Yale 
University and the National Cancer Institute. Human breast adenocarcinoma cells (MCF-
7) (American Type Culture Collection, Manassas, VA) were maintained as monolayer 
cultures in 25 cm
2
 polystyrene culture flasks (Falcon, Becton Dickinson BioScience, Le 
Pont de Claix, France) in Dulbecco's Modified Eagle's Medium (DMEM) supplemented 
with 10% fetal bovine serum, 1% penicillin-streptomycin (Invitrogen, Carlsbad, CA). 
Human breast MCF10a cells were maintained as monolayer cultures in 25 cm
2
 
polystyrene culture flasks (Falcon, Becton Dickinson BioScience, Le Pont de Claix, 
France) in MEGM medium (American Type Culture Collection, Manassas, VA), 100 
ng/ml cholera toxin (Sigma-Aldrich, St. Louis, MO), and 1% penicillin-streptomycin 
(Invitrogen, Carlsbad, CA) . 
Human HeLa cervical cancer cells (American Type Culture Collection, Manassas, VA) 
were maintained as monolayer cultures in RPMI 1640 medium (Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (Invitrogen) and 1% penicillin/streptomycin 
(Sigma-Aldrich, St. Louis, MO). Cells were incubated at 37°C in a humid atmosphere 
containing 5% CO2 and subcultured every 2-3 days. 
Human End1 cervical cells (American Type Culture Collection, Manassas, VA) were 
maintained as monolayer cultures in KSFM medium (Invitrogen, Carlsbad, CA) 
15 
 
 
supplemented with 0.1 human recombinant EGF (Invitrogen), and 0.05 mg/ml bovine 
pituitary extract (Invitrogen). Cells were incubated at 37°C in a humid atmosphere 
containing 5% CO2 and subcultured every 2-3 days.  
Human Farage B-cell lymphoma and RPMI 1788 B cells (American Type Culture 
Collection, Manassas, VA) were maintained in RPMI 1640 medium (Invitrogen, 
Carlsbad, CA) supplemented with 10% and 20% fetal bovine serum (Invitrogen), 
respectively. Cells were incubated at 37°C in a humid atmosphere containing 5% CO2 
and subcultured every 2-3 days. 
Pre-designed siRNA oligos (iDT) were used to knock down the expression of PIWIL1 
and L4 in the cell lines described above. Transfection of the siRNA was performed using 
LipofectamineTM RNAiMAX (Invitrogen). AllStars Negative Control siRNA (Qiagen) 
was used to ensure minimal nonspecific effects on gene expression and phenotype as it 
exhibits no homology to any known mammalian gene. Each oligonucleotide was reverse-
transfected in 6-well plates with 30,000 cells/well at a final concentration of 25 nM. After 
incubation at 37℃ and 5% CO2 for 48 hr, total RNA samples were isolated. 
RNA isolation and quantification 
Isolation of total RNA from transfected cell lines was conducted using the miRNeasy 
Mini Kit (Qiagen), according to the protocol of the manufacturer for mammalian cells 
and tissues. On-column DNase digestion (Qiagen) was also conducted during the 
isolation of RNA. The quantification of isolated RNA was measured on an Epoch 
Microplate Spectrophotometer (Biotek, Winooski, VT). First-strand cDNA conversion 
16 
 
 
was performed using the AffinityScript Multi Temperature cDNA Synthesis Kit (Agilent 
Technologies). 
PIWI Gene Expression Measurement by Quantitative RT-PCR  
PIWI mRNAs expression levels were measured by quantitative real-time PCR performed 
in technical triplicate using the KAPA SYBR FAST Universal qPCR Kit (KAPA 
Biosystems) via a standard thermal cycling procedure on an ABI 7500 instrument 
(Applied Biosystems). RNA quantity was normalized using the HPRT housekeeping 
gene and quantified using the 2
-ΔΔCt
 method. The SYBR Green detection using the 
following primers: 
PIWIL1 
5’-AATAATATTTTCAGGAGGCTTTTG-3’ 
5’-AATCACCAACCTGTGACTTGG-3’ 
PIWIL2 
5’-CCAGCACAAAGGGAGTCTGT-3’ 
5’-GCCTCTACCTGATGGAAGCA-3’ 
PIWIL3 
5’-TTTAGAAGAACTTTCAAGCTGCTG-3’ 
5’-TCCAAACTGGTCCCATGACG-3’ 
PIWIL4 
5’-TTCCCCAGCACAAATTATCC-3’ 
5’-ACGTCTGGGTGAAACAGGAC-3’ 
 
Cell Proliferation Assay 
MCF7, MCF10a, Hela, End1, Farage, and RPMI 1788 cells were transfected with siRNA 
oligos targeting PIWIL1 or PIWIL4 and a scrambled sequence negative control in 96-
well plates using the Lipofectamine RNAiMAX transfection reagent. Cell proliferation 
was measured in triplicate at baseline, 24 hours, 48 hours, 72 hours, and 96 hours (some 
groups extend to 144 hours) using the CellTiter 96® AQueous One Solution Cell 
Proliferation Assay (MTS) kit (Promega Corporation, Madison, WI). 20 µL of MTS dye 
17 
 
 
were added to each well and allowed to incubate with transfected cells in a 37ºC CO2 
incubator for 2 hours.  Following incubation, MTS-stained cells were quantified using an 
Epoch Microplate Spectrophotometer.   
Western Blotting 
Standard western blotting technique was used. Briefly, total protein lysate was collected 
from cells using RIPA buffer (Santa Cruz Biotechnology) and 30 ug were run on a 10% 
NuPAGE Bis-Tris gel (Life Technologies). PVDF membranes were incubated overnight 
at 4ºC with the following primary antibodies:  PIWIL4 (1:1000, abcam 111714) or β-
actin (1:2000 Santa Cruz Biotechnology). 
Statistical Analysis 
Statistical analyses were performed using the SAS statistical software, version 9.3 (SAS 
Institute). Student t-tests and one-way ANOVA were applied to calculate differences in 
PIWIL4 expression across different tumor types. A repeated-measures, mixed-design 
ANOVA model was used to assess whole curve differences in proliferation rate between 
transfection groups by measuring the interaction between transfection type and time.   
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RESULTS 
PIWIL1 was significantly hypomethylated among long-term night shiftworkers  
As previously reported
14
, our whole-genome methylation analysis identified differential 
methylation between day workers and long-term shiftworkers at 5409 CpG sites, 
corresponding to 4752 genes, after adjusting for multiple comparisons. Among all 27,578 
CpG sites analyzed, a total of 4 CpG sites were located in the PIWI gene regions, 
including 2 in PIWIL1 and 2 in PIWIL2, covering the proximate promoter (TSS1500) or 
the 5’ UTR/TSS200 region. Compared to day workers, all 4 CpG sites showed decreased 
methylation in shiftworkers.  Methylation indices for day and shiftworkers at each of 
these CpG sites are presented in Figure 1. Of these 4 hypomethylated CpG sites, the 
cg13861644 site covering the proximal promoter region of PIWIL1 showed a statistically 
significant difference between day and shiftworkers at Q < 0.001, with a decrease in 
methylation level among night shiftworkers greater than 10% (Δ=13.14%, Q=2.32*10-6).  
These results demonstrated that both PIWIL1 and PIWIL2 were hypomethylated to 
different extents in night shiftworkers. As previously reported
4
, the odds ratio for breast 
cancer among women who worked as night shiftworkers in this population was 1.5 
(95%CI: 1.2 to 1.7) compared to day workers. Typically, hypomethylation that occurs at 
CpG sites in the promoter region is associated with gene activation. The significant 
decrease in methylation at cg13861644 in the PIWIL1 promoter might result in 
overexpression of PIWIL1 among night shiftworkers, which might in turn be associated 
with the increased breast cancer risk in this population. Further in-depth investigations 
using existing expression array data and molecular methods were used to explore whether 
PIWI genes have potential oncogenic roles in breast tumorigenesis.  
19 
 
 
The Oncomine Database Indicates Differential Expression of PIWI Genes in Breast 
Cancer Compared to Normal Breast Tissue 
To investigate the role of PIWI genes in breast tumorigenesis, a comprehensive search of 
the Oncomine database was conducted. Searching for PIWI gene expression in “cancer 
vs. normal” tissues in the Oncomine database returned a total of 36 analyses from 12 
unique studies in breast cancer. 5 out of the 36 analyses were identified as statistically 
significant with P-values < 0.05. A bubble plot was generated using -log10 transformed 
P-values and the fold change of PIWI gene expression in breast tumor versus normal 
breast tissues extracted from each analysis. The size of each circle is proportional to the 
sample size of the analysis it corresponds to (Figure 2). The plot indicates that PIWI 
gene expression is frequently altered in multiple breast tumor subtypes, including 
invasive ductal breast carcinoma, ductal breast carcinoma, invasive lobular breast 
carcinoma and fibroadenoma. Specifically, 8 out of the 10 analyses with PIWIL1 
expression data exhibited increased PIWIL1 expression in breast tumor relative to normal 
breast tissues while only two showed decreased expression (Figure 2A). Among them, 
three analyses showed statistical significant (P<0.05) higher PIWIL1 expression ranging 
from 1.033- to 1.407-fold in breast tumor compared to normal tissues. Similarly, 6 out of 
the 9 analyses with PIWIL2 expression data exhibited increased PIWIL2 expression in 
breast tumor relative to normal breast tissues, while three showed decreased expression 
(Figure 2B). Only one analysis (Finak, invasive breast carcinoma) showed a statistical 
significant expression change (p=6.3*10
-6
) with 1.307 times higher PIWIL2 expression in 
tumor compared to normal tissue. Interestingly, while analyses with relative small sample 
sizes (<100) tended to report higher PIWIL2 gene expression, studies with large sample 
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sizes (~1000) tended to reveal slightly decreased PIWIL2 expression in tumor versus 
normal tissue. Only 4 studies had expression data available for PIWIL3 and 3 out of the 4 
analyses exhibited statistically non-significant decreased PIWIL3 expression in breast 
tumor relative to normal breast tissues while one showed highly statistically significant 
increased expression (fold change=2.85, p=1.1*10
-12
) in tumor relative to normal tissue 
(Figure 2C). In addition, 7 out of the 13 analyses with PIWIL4 data exhibited increased 
PIWIL4 expression in breast tumor relative to normal tissues while 6 showed decreased 
expression (Figure 2D). While the analysis results of PIWIL4 were inconsistent across 
different studies, none of the analyses were statistically significant at p=0.05. 
In conclusion, the results derived from the Oncomine database showed that the 
expression of PIWI genes is up-regulated in breast tumor vs. normal tissues in the 
majority of the analyses (22 out of 36). Moreover, all studies where expression 
differences achieved statistical significance revealed higher PIWI gene expression in 
breast tumor tissues. While most studies report up-regulated expression of PIWIL1 and 
PIWIL2 in breast cancer, the expression differences in PIWIL3 and PIWIL4 were 
inconsistent. In vitro experiments were needed and therefore performed to further explore 
the oncogenic role of PIWI genes in breast tumorigenesis. 
 
PIWI Gene Expression is Upregulated in Multiple Cancer Cell Lines Compared to 
Normal Tissue Cells 
To investigate the role of PIWI genes in breast tumorigenesis, we measured the relative 
expression levels of all four PIWI genes in MCF7 breast cancer and MCF10a normal 
breast cells. As shown in Figure 3, PIWI gene mRNA expression levels were all 
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significantly different between MCF7 and MCF10a cells. Consistent with our finding of 
PIWIL1 hypomethylation in the night shiftworkers, who may be at higher risk of breast 
cancer, the expression of PIWIL1 in MCF7 cells was 5.57 times higher compared to that 
in MCF10a cells (p<0.01). Similarly, PIWIL3 was 4.194 times overexpressed in MCF7 
cells (p<0.01). More dramatic is the finding of a 15.6-fold increase in PIWIL4 expression 
in MCF7 cells (p<0.01), the result of which remained consistent through multiple 
repetitions of the experiment. Meanwhile, inconsistent with the Oncomine and 
methylation analysis, PIWIL2 was found to be 4.193 times underexpressed in MCF7 cells 
(p<0.01). 
To investigate whether PIWIL1 and PIWIL4 had similar expression patterns in other 
cancer types, we also measured their relative mRNA expression levels cervical cancer 
(Hela) and normal cervical cells (End1), as well as non-Hodgkin’s lymphoma (Farage) 
and normal B cells (RPM 1788). 
As shown in Figure 4, the expression patterns of PIWIL1 and PIWIL4 in cervical cancer 
vs. normal cervical cells were similar to those found in our breast cell lines. However, in 
non-Hodgkin’s lymphoma cell lines, while PIWIL1 was 3.59 times overexpressed 
compared to normal B cells, PIWIL4 was 28.14 times underexpressed, indicating that 
PIWIL4 might not be required for the growth of non-Hodgkin’s lymphoma cells. 
Upon considering all the evidence, the expression of PIWIL1 and PIWIL4 exhibited the 
most consistency across the various analyses, and were thus chosen as candidate genes 
for further functional analysis. 
* 
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Knocking Down PIWIL1/PIWIL4 Decreases Breast Cancer Cell Proliferation Rate 
As suggested by the findings of our analyses, we tested PIWIL1 and PIWIL4’s potential 
role in cellular growth and proliferation using a MTS assay. Two sets of pre-designed 
siRNA oligos were used to knock down PIWIL1 and PIWIL4 in MCF7 breast cancer and 
MCF10a normal breast cell lines. As shown in Figure 5A, transfection with PIWIL1-
targeting siRNA oligos significantly decreased MCF7 cell growth compared to the 
negative control (P < 0.0001). Moreover, the PIWIL1 knockdown had an immediate and 
obvious effect within 24 hours after transfection, and 98% of the cells died after 48 hours. 
In contrast, over 60% of MCF10a cells survived and maintained growth after 48 hours 
following transfection (Figure 5B). The results were consistent with our previous finding 
of a 5.57-fold increase in PIWIL1 expression in MCF7 breast cancer cells compared to 
MCF10a normal breast cells, indicating that PIWIL1 may be essential for the cellular 
proliferation in MCF7 cells while being less important for MCF10a cells. 
A similar pattern was observed for PIWIL4, where MCF7 cells transfected with PIWIL4-
targeting siRNA oligos had a statistically significant decrease in proliferation rate 
compared to negative control cells (P < 0.0001). The effect of knocking down PIWIL4 in 
MCF7 cells was also lethal, and almost all cells stopped growing within 24 hours, with an 
over 95% death rate within 48 hours (Figure 5C). In contrast, PIWIL4 knockdown only 
moderately affected MCF10a proliferation, and 50% of the cells remained alive and 
growing after 48 hours compared to the negative control (P<0.05) (Figure 5D). The 
dramatic decrease in cellular proliferation rate resulted from the knockdown of PIWIL4 
in MCF7 cells was also consistent with our previous finding of a 15.9-fold increase in 
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PIWIL4 expression in MCF7 vs. MCF10a cells, which suggests that PIWIL4 may also 
play a much more important role in the proliferation of MCF7 compared to MCF10a cells. 
To investigate whether PIWIL4 had a similar effect in other cancer types, we also 
conducted cell proliferation assays using our PIWIL4-targeting siRNA in cervical cancer 
cells as well as non-Hodgkin’s lymphoma cells. 
As shown in Figure 6A, transfection with PIWIL4-targeting siRNA oligos significantly 
decreased Hela cell growth compared to the negative control (P < 0.0001), and almost 75% 
of transfected Hela cells died after 96 hours.  Meanwhile, transfected End1 normal 
cervical cells were only moderately affected at 24 hours after transfection (Figure 6B). 
The results were also consistent with our previous finding of a 3.96-fold increase in 
PIWIL4 expression in Hela cervical cancer vs. End1 normal cervical cells, which, again, 
suggests that PIWIL4 may be essential for the cellular growth and proliferation of Hela 
cells. 
Interestingly, knocking down PIWIL4 in both Farage and RPM1788 cells did not result in 
altered cell proliferation rates compared to the negative controls. This, again, was also 
consistent with our previous finding of a 28.14-fold decrease in PIWIL4 expression in 
Farage NHL vs. RPMI 1788 normal B-cells, which suggests that PIWIL4 might not be 
essential for the cellular proliferation of Farage cells. 
Confirmation of PIWIL4’s Knockdown in the Functional Studies 
Since the siRNA used to knockdown PIWIL4 targeted its 3’UTR region, silencing was 
likely to have taken place at the post-transcriptional level. Therefore, Western blotting 
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and dot blotting were conducted to further confirm the knockdown of PIWIL4 in 
previous functional studies, where the protein level of PIWIL4 in cells transfected with 
PIWIL4-targeting siRNA oligos and negative control cells were compared. As shown in 
Figure 7, the knockdown was confirmed in both MCF7 cells and MCF 10a cells 
transfected with PIWIL4-targeting siRNA oligos, indicating that the phenomenal impact 
observed in our functional analyses was likely the result of PIWIL4 knockdown. 
 
DISCUSSION 
 
As shiftwork has been defined as ‘probably carcinogenic to humans’ by IARC and a large 
percentage of the working population are engaged in shiftwork, the adverse health effects 
of shiftwork, which range from cardiovascular disease and cancer, have been widely 
investigated by many epidemiologic studies. However, few studies have ventured to 
study the molecular mechanisms underlying the connection between shiftwork and 
disease. 
Using samples from the Danish “Diet, Cancer and Health” prospective cohort, our 
research group has previously reported that long-term exposure to shiftwork can alter 
epigenetic patterns
17
, and that there were statistically significant differences in 
methylation at many imprinted genes in shiftworkers compared to their day working 
counterparts
18
. The result of this study is consistent with these findings, and specifically 
show that exposure to shiftwork results in a significant decrease in the promoter 
methylation of PIWIL1. Although the molecular mechanisms underlying how long-term 
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night shiftwork may induce epigenetic alterations in cancer-related genes and increased 
breast cancer risk remain obscure, our findings of a potential oncogenic role for PIWIL1 
and PIWIL4 in breast tumorigenesis may provide a possible missing link. 
PIWI proteins, previously reported to be expressed predominantly in the germline, have 
recently been documented to have ectopic expressions in a variety of cancers. 
Specifically, PIWIL1 was first detected in seminomas
19
 and later in pancreatic cancer
20
, 
cervical cancer
21
, colorectal cancer
22
, liver cancer
23
 and lung cancer
24
. Aberrant 
expression of PIWIL2 was reported in seminoma
25
, breast cancer
26
, cervical cancer
27
, 
ovarian cancer
28
, and gastric cancer
29
. PIWIL3 was only found to be expressed in gastric 
cancer and PIWIL4 was overexpressed in gastric cancer and cervical cancer 
30
. Up to date, 
our study is the first to report the DNA hypomethylation of PIWIL1 in a shiftworkers, a 
population that has been observed to carry a higher risk of developing breast cancer. 
Moreover, we are also the first to observe overexpression of PIWIL1 and PIWIL4 in 
breast cancer cells. 
Despite the accumulation of evidence of aberrant PIWI gene expression in cancer, studies 
attempting to elucidate the detailed molecular mechanism of PIWI proteins in 
tumorigenesis remain scarce
31
. Possible proposed mechanisms include: (1) PIWIL1-
associated DNA methylation and cyclin-dependent kinase inhibitor (CDKI) silencing in 
sarcomas
32
; (2) PIWIL2-induced activation of antiapoptotic factor BCLX and STAT3 in 
a fibroblast cell line
26
; and (3) PIWIL4-induced promotion of cervical cancer cell growth 
and invasion via inhibition of apoptosis through the p53/p14ARF. So far, these studies 
represent the strongest evidence in support of a potential oncogenic role for PIWI genes 
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in breast tumorigenesis. In the present study, we used siRNA oligos to knockdown 
PIWIL1 and PIWIL4 and demonstrated that they were essential for the cellular growth 
and proliferation of MCF7 breast cancer cells. This finding is concurrent with our finding 
of PIWIL1 hypomethylation in night shiftworkers, who are at higher risk of breast cancer.  
The consistency of these disparate observations suggest that shiftwork may be able to 
trigger epigenetic alterations at potential oncogenic genes, including members of the 
PIWI family, which may in turn lead to the promotion of cancer cell growth and 
increased risk of breast cancer. Further analyses, including examinations of genes 
affected by PIWI gene knockdown, are required to further reveal the potential cancer 
related pathways PIWI genes may be involved in and identify downstream targets. 
Furthermore, as our observation of rapid breast cancer cell death following PIWIL1 and 
L4 knockdown is consistent with previously published data implicating them in cellular 
apoptosis, further functional analyses examining the role in apoptosis-related pathways 
are needed to attain a more comprehensive understanding of the impact of PIWI genes in 
breast cancer cell viability. 
As shown in Figure 8, the prediction results derived using the STRING platform 
indicated that PIWI proteins likely interact with core RNA-mediated gene silencing and 
transcriptional regulatory factors. In addition, consistent with previous studies and our 
findings, PIWIL4 was also predicted to interact with DNMT3L, which is involved in the 
induction of de novo DNA methylation.  
As gene expression in tumorigenesis is known to be controlled by small regulatory non-
coding RNA, there have been numerous works exploring the role of small RNAs in 
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cancer. The role of miRNAs and their gene targets have been elucidated and 
characterized in various cancer types
13
. Similarly, as PIWI proteins bind to PIWI-
interacting RNAs (piRNAs), they may also play a critical role in the regulation of gene 
expression in cancer tissues via the PIWI/piRNA pathway. However, in contrast to the 
voluminous amount of experimental and observational evidence elucidating the miRNA-
cancer connection, little is known about the role of the PIWI/piRNA axis in the 
carcinogenic process. Aside from robust in vivo and in vitro models, more systematic and 
large-scale studies are thus needed to obtain a more comprehensive understanding of the 
role of PIWI proteins and piRNAs in the carcinogenic process. 
As the knockdown of PIWIL1 and L4 greatly limited the growth of MCF7 breast cancer 
cells while exerting only a moderate effect on immortalized normal MCF10a breast cells, 
a potential therapeutic strategy might take advantage of the preferential effect of PIWI 
genes on breast tumor tissues. In fact, in our recent pilot animal study, direct injection 
with siRNA-targeting PIWIL4 via delivery reagents (in vivo Jet PEI) indeed significantly 
decreased tumor size with a 90% inhibition rate on mice planted with MCF7 cells, 
demonstrating consistency with our in vitro functional analyses. Again, additional studies 
with larger sample sizes are required to further elucidate the capacity of PIWI genes as 
therapeutic targets. 
This study has several limitations. Because of the unavailability of breast tissue samples 
in the Danish prospective cohort, we were unable to investigate the potential correlation 
between PIWI methylation changes in peripheral blood leukocytes and expression 
changes in the breast experimentally. Another limitation is that the findings of the whole-
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genome methylation analysis were based on a limited sample size, which in turn limited 
the statistical power by which interpretations could be made. As such, the results from the 
shiftwork methylation analysis should be interpreted carefully, as the degree to which 
they are generalizable cannot be known without further confirmation in an independent 
study population. Meanwhile, as mentioned above, additional functional studies, 
expression array measurements, and in vivo animal work are needed before we can claim 
PIWIL1 and PIWIL4 as important players in the breast carcinogenic process. 
CONCLUSION 
 
In summary, our findings provide the first evidence of a link between an epigenetic 
change in PIWI genes and night shiftwork. Moreover, the findings from our expression 
analyses and functional experiments both suggest that PIWIL1 and PIWIL4 may play an 
oncogenic role in breast tumorigenesis. Future mechanistic investigation into the function 
of PIWI genes is needed to further elucidate their role in breast carcinogenesis and to 
better inform the development of novel therapeutic strategies. 
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